rs28465565
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_033380.3(COL4A5):c.3553+42T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0314 in 1,064,300 control chromosomes in the GnomAD database, including 4,286 homozygotes. There are 8,964 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.13 ( 2234 hom., 4092 hem., cov: 23)
Exomes 𝑓: 0.019 ( 2052 hom. 4872 hem. )
Consequence
COL4A5
NM_033380.3 intron
NM_033380.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.271
Publications
2 publications found
Genes affected
COL4A5 (HGNC:2207): (collagen type IV alpha 5 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Mutations in this gene are associated with X-linked Alport syndrome, also known as hereditary nephritis. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Aug 2010]
COL4A5 Gene-Disease associations (from GenCC):
- Alport syndromeInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen, G2P
- X-linked Alport syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Genomics England PanelApp, Myriad Women’s Health, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant X-108666636-T-C is Benign according to our data. Variant chrX-108666636-T-C is described in ClinVar as Benign. ClinVar VariationId is 1267016.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.435 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.134 AC: 14925AN: 111550Hom.: 2233 Cov.: 23 show subpopulations
GnomAD3 genomes
AF:
AC:
14925
AN:
111550
Hom.:
Cov.:
23
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0522 AC: 6224AN: 119139 AF XY: 0.0399 show subpopulations
GnomAD2 exomes
AF:
AC:
6224
AN:
119139
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0193 AC: 18422AN: 952695Hom.: 2052 Cov.: 19 AF XY: 0.0185 AC XY: 4872AN XY: 263657 show subpopulations
GnomAD4 exome
AF:
AC:
18422
AN:
952695
Hom.:
Cov.:
19
AF XY:
AC XY:
4872
AN XY:
263657
show subpopulations
African (AFR)
AF:
AC:
10149
AN:
22671
American (AMR)
AF:
AC:
1569
AN:
28600
Ashkenazi Jewish (ASJ)
AF:
AC:
69
AN:
18067
East Asian (EAS)
AF:
AC:
3277
AN:
27091
South Asian (SAS)
AF:
AC:
715
AN:
47674
European-Finnish (FIN)
AF:
AC:
7
AN:
38052
Middle Eastern (MID)
AF:
AC:
61
AN:
3746
European-Non Finnish (NFE)
AF:
AC:
557
AN:
725776
Other (OTH)
AF:
AC:
2018
AN:
41018
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
465
931
1396
1862
2327
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
342
684
1026
1368
1710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.134 AC: 14947AN: 111605Hom.: 2234 Cov.: 23 AF XY: 0.121 AC XY: 4092AN XY: 33845 show subpopulations
GnomAD4 genome
AF:
AC:
14947
AN:
111605
Hom.:
Cov.:
23
AF XY:
AC XY:
4092
AN XY:
33845
show subpopulations
African (AFR)
AF:
AC:
13425
AN:
30413
American (AMR)
AF:
AC:
699
AN:
10556
Ashkenazi Jewish (ASJ)
AF:
AC:
7
AN:
2644
East Asian (EAS)
AF:
AC:
510
AN:
3541
South Asian (SAS)
AF:
AC:
60
AN:
2695
European-Finnish (FIN)
AF:
AC:
1
AN:
6105
Middle Eastern (MID)
AF:
AC:
0
AN:
213
European-Non Finnish (NFE)
AF:
AC:
84
AN:
53239
Other (OTH)
AF:
AC:
161
AN:
1514
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
323
646
970
1293
1616
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
134
268
402
536
670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.